Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1263421.RAQCO-cI-_FyyxhNKnzzN9ENr3lQkrdutvIER2exoKYYo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1263421.RAQCO-cI-_FyyxhNKnzzN9ENr3lQkrdutvIER2exoKYYo130_assertion type Assertion NP1263421.RAQCO-cI-_FyyxhNKnzzN9ENr3lQkrdutvIER2exoKYYo130_head.
- NP1263421.RAQCO-cI-_FyyxhNKnzzN9ENr3lQkrdutvIER2exoKYYo130_assertion description "[Our study goals are to expand the evaluation of this association to a larger group of patients; to evaluate the association of aberrant CD7 expression in AMLs with D835 mutation, not previously done; to evaluate if aberrant CD7 expression may serve as a surrogate marker for predicting FLT3 mutational status; to evaluate if combined FLT3 with NPM1 mutational status has a better correlation with CD7 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1263421.RAQCO-cI-_FyyxhNKnzzN9ENr3lQkrdutvIER2exoKYYo130_provenance.
- NP1263421.RAQCO-cI-_FyyxhNKnzzN9ENr3lQkrdutvIER2exoKYYo130_assertion evidence source_evidence_literature NP1263421.RAQCO-cI-_FyyxhNKnzzN9ENr3lQkrdutvIER2exoKYYo130_provenance.
- NP1263421.RAQCO-cI-_FyyxhNKnzzN9ENr3lQkrdutvIER2exoKYYo130_assertion SIO_000772 25679063 NP1263421.RAQCO-cI-_FyyxhNKnzzN9ENr3lQkrdutvIER2exoKYYo130_provenance.
- NP1263421.RAQCO-cI-_FyyxhNKnzzN9ENr3lQkrdutvIER2exoKYYo130_assertion wasDerivedFrom befree-2016 NP1263421.RAQCO-cI-_FyyxhNKnzzN9ENr3lQkrdutvIER2exoKYYo130_provenance.
- NP1263421.RAQCO-cI-_FyyxhNKnzzN9ENr3lQkrdutvIER2exoKYYo130_assertion wasGeneratedBy ECO_0000203 NP1263421.RAQCO-cI-_FyyxhNKnzzN9ENr3lQkrdutvIER2exoKYYo130_provenance.